Physician profile
Yanira Marcano
NPI 1801175757
$1,995.68
in general payments reported to CMS, 2019-2025
18 companies · $20.69 in 2025
The $20.69 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $72.73 · 2021: $161 · 2022: $998 · 2023: $316 · 2025: $20.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $555.59 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.89 | 2019-2023 | Xifaxan, Trulance |
| Abbott Laboratories | $239.47 | 2022-2025 | Freestyle Libre 2, Proclaim |
| Bayer Healthcare Pharmaceuticals INC. | $217.00 | 2022-2023 | |
| Abbvie INC. | $121.10 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $102.36 | 2022 | |
| Novo Nordisk INC | $85.56 | 2019-2023 | Ozempic |
| Merck Sharp & Dohme LLC | $84.99 | 2019-2023 | Gardasil 9, M-M-R II, Vaxneuvance |
| Cranial Technologies, INC | $83.52 | 2020-2023 | Doc Band |
| Lilly USA, LLC | $42.37 | 2019-2023 | Jardiance |
| Sanofi Pasteur INC. | $34.89 | 2023 | |
| Nevro Corp. | $33.47 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.40 | 2022 | |
| Amarin Pharma, INC. | $23.68 | 2019 | |
| Shield Therapeutics INC | $18.71 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.88 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $15.02 | 2023 | |
| Lucid Diagnostics INC. | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanira Marcano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.